Anavex Life Sciences Corp (AVXL)

[Investor2014]

So from what you are saying there seems no practical reason why Anavex could not have delivered more detailed substation of the met all endpoints claims by now?

In that case there must be other reasons that Anavex only delivered a new slide layout yesterday with the same information provided in the "fixed" post CTAD update slide deck.

The anticipation of the 12th Jan update that never materialised is of course why $AVXL is down today. No cabal needed, just the sobering fact that the market overall have more objective investors than WGT ones.

Do you have any guess as to when the full analysis might be done for regulatory submission and the expected peer reviewed paper, or is your $AVXL position now so small its not worth engaging in such guess work?

I'll stick with Feb'ish 2024, which has worked out right before.

Will that leave time to submit the EXCELLENCE results for potential regulatory approval before, is another good questions.